Already decades in development, the SARS-CoV-2 pandemic first thrust mRNA therapeutics into the limelight. From vaccines, immunotherapies and protein replacement to gene editing and cell reprogramming, interest in mRNA manufacturing has surged. Today, therapeutic developers have the room and attention to bring innovations to market. Competition is growing. Regulations are crystalizing.
Remaining at the front of this fast-paced therapeutic space hinges not only on ideas and implementation, but also on development speed and product safety. As a manufacturer, the first are your expertise. As a long-standing global supplier of raw materials, we help make the latter happen. We help you strengthen your supply chain, ease transfers to manufacturing, secure continuous production, and create consistently high-quality products.
This is the “why” of CustomBiotech: GMP Grade and fit-for-purpose raw materials to seize opportunities that improve healthcare.